Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -56.84x is 139% below its 1-year average of -23.77x, near the low end of its 1-year range (-56.84x–-0.42x).
As of the fiscal period ended Friday, March 31, 2023. 99.85% below its 12-month average of -28.44x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -56.84x.
INTEREST COVERAGE RATIO
-56.84x
INTEREST COVERAGE RATIO AVG TTM
-28.44x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-99.85%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 450 covered companies
CURRENT VS SECTOR MEDIAN
-926.01%
vs the sector median at left
INmune Bio, Inc.
Market Cap
$50.80M
Interest Coverage Ratio
-56.84x
TTM Avg
-28.44x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.96M
Interest Coverage Ratio
-14.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.39M
Interest Coverage Ratio
-13.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.36M
Interest Coverage Ratio
N/A
TTM Avg
254.37x
3Y Avg
222.37x
5Y Avg
222.37x
Market Cap
$51.70M
Interest Coverage Ratio
-6.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.05M
Interest Coverage Ratio
3.24x
TTM Avg
3.06x
3Y Avg
3.54x
5Y Avg
8.88x
Market Cap
$49.93M
Interest Coverage Ratio
-9.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $50.80M | -56.84x | -28.44x | N/A | N/A |
| Clene Inc. (CLNN)vs › | $51.56M | -8.61x | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $50.96M | -14.01x | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.39M | -13.25x | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.36M | N/A | 254.37x | 222.37x | 222.37x |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.70M | -6.14x | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $52.05M | 3.24x | 3.06x | 3.54x | 8.88x |
| Celularity Inc. (CELU)vs › | $49.93M | -9.08x | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | N/A | N/A | N/A | N/A |
Interest Coverage
-56.8x
Debt/Equity
0.07
Current Ratio
4.04
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -56.84x |
| 2022-12-31 | -29.54x |
| 2022-09-30 | -26.39x |
| 2022-06-30 | -14.20x |
| 2022-03-31 | -15.24x |
| 2021-12-31 | -0.42x |
